2015

1. Effectiveness and safety of first-generation protease inhibitors in clinical practice: Hepatitis C virus patients with advanced fibrosis

   World Journal of Gastroenterology, Vol. 21, Núm. 30, pp. 9163-9174

2. Entecavir has high efficacy and safety in white patients with chronic hepatitis B and comorbidities

   European Journal of Gastroenterology and Hepatology, Vol. 27, Núm. 1, pp. 46-54

3. Safety and efficacy of triple therapy with peginterferon, ribavirin and boceprevir within an early access programme in Spanish patients with hepatitis C genotype 1 with severe fibrosis: SVRw12 analysis

   Liver International, Vol. 35, Núm. 1, pp. 90-100

4. Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: The International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program

   Journal of Viral Hepatitis, Vol. 22, Núm. 5, pp. 469-480